Bortezomib will raise the amount or result of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. Improved flibanserin adverse consequences may possibly happen if coadministered with a number of weak CYP3A4 inhibitors. This medication is utilised to treat certain different types of cancer (for instance a https://abbak665whs8.wikissl.com/user